Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Orthopediatrics (KIDS) Enterprise Value (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Enterprise Value for 10 consecutive years, with -$19.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Enterprise Value rose 71.59% to -$19.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$19.6 million, a 71.59% increase, with the full-year FY2025 number at -$19.6 million, up 71.59% from a year prior.
  • Enterprise Value was -$19.6 million for Q4 2025 at Orthopediatrics, down from -$18.9 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$9.0 million in Q4 2021 to a low of -$118.3 million in Q4 2022.
  • A 5-year average of -$55.5 million and a median of -$52.1 million in 2022 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: skyrocketed 89.27% in 2021, then crashed 1213.46% in 2022.
  • Orthopediatrics' Enterprise Value stood at -$9.0 million in 2021, then plummeted by 1213.46% to -$118.3 million in 2022, then surged by 32.11% to -$80.3 million in 2023, then rose by 14.29% to -$68.8 million in 2024, then soared by 71.59% to -$19.6 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Enterprise Value are -$19.6 million (Q4 2025), -$18.9 million (Q3 2025), and -$46.6 million (Q2 2025).